MetaCap

Shattuck Labs Insider Trades

NASDAQ: STTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.97+0.31 (+5.48%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 5.97 0.00%

Last 12 months

Purchases
1 · $250.00K
Sales
6 · $591.85K
Shares bought / sold
62.50K / 85.91K
Net activity
Net selling $341,850

Shattuck Labs insider activity

Over the last 12 months, Shattuck Labs insiders reported 26 transactions on SEC Form 4: 1 open-market purchase and 6 sales. Insiders bought $250,000 and sold $591,850 worth of stock, for net insider selling of $341,850. The largest seller was Pandite Arundathy N., with $408,600 in reported sales.

The most recent filing shows Shukla Abhinav A. (Chief Technical Officer) reporting a transaction in 12,153 shares at $3.57 on Jul 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put STTK's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

STTK insider transactions

Shattuck Labs insider transactions
DateInsiderTypeSharesValueFiling
Jul 6, 2026Shukla Abhinav A.Chief Technical OfficerOption exercise12,153$43.39KForm 4
Jul 2, 2026Shukla Abhinav A.Chief Technical OfficerSale410$2.87KForm 4
Jul 2, 2026Shukla Abhinav A.Chief Technical OfficerOption exercise410$1.46KForm 4
Jul 1, 2026Shukla Abhinav A.Chief Technical OfficerSale100$707Form 4
Jul 1, 2026Shukla Abhinav A.Chief Technical OfficerOption exercise100$357Form 4
Jun 30, 2026Shukla Abhinav A.Chief Technical OfficerSale23,365$165.42KForm 4
Jun 30, 2026Shukla Abhinav A.Chief Technical OfficerOption exercise23,365$83.41KForm 4
Jun 30, 2026Pandite Arundathy N.Chief Medical OfficerSale30,000$210.30KForm 4
Jun 9, 2026SIEGALL CLAY BDirectorBuy62,500$250.00KForm 4
May 22, 2026SIEGALL CLAY BDirectorAward128,054$138.89KForm 4
May 21, 2026Shukla Abhinav A.Chief Technical OfficerAward5,122$5.56KForm 4
May 15, 2026Stout StephenSee RemarksAward12,805$13.89KForm 4
May 12, 2026Schreiber TaylorChief Executive OfficerAward25,610$27.78KForm 4
May 12, 2026Neill Andrew RChief Financial OfficerAward64,027$69.44KForm 4
May 12, 2026Pandite Arundathy N.Chief Medical OfficerSale30,000$198.30KForm 4
May 12, 2026Shukla Abhinav A.Chief Technical OfficerSale2,032$14.24KForm 4
May 12, 2026Shukla Abhinav A.Chief Technical OfficerOption exercise2,032$7.25KForm 4
May 10, 2026Stout StephenSee RemarksTax withholding968$6.63KForm 4
Jan 25, 2026Neill Andrew RChief Financial OfficerTax withholding2,589$10.74KForm 4
Jan 25, 2026DeYoung CasiChief Business OfficerTax withholding2,286$9.49KForm 4
Jan 25, 2026Stout StephenSee RemarksTax withholding593$2.46KForm 4
Jan 25, 2026Pandite Arundathy N.Chief Medical OfficerTax withholding3,195$13.26KForm 4
Jan 10, 2026Neill Andrew RChief Financial OfficerTax withholding6,660$31.64KForm 4
Jan 10, 2026DeYoung CasiChief Business OfficerTax withholding5,699$27.07KForm 4
Jan 10, 2026Stout StephenSee RemarksTax withholding4,153$19.73KForm 4
Jan 10, 2026Pandite Arundathy N.Chief Medical OfficerTax withholding6,851$32.54KForm 4
Aug 25, 2025SIEGALL CLAY BDirectorAward128,054$111.11KForm 4
Aug 25, 2025Neill Andrew RChief Financial OfficerAward64,027$55.56KForm 4
Aug 25, 2025Stout StephenSee RemarksAward12,805$11.11KForm 4
Aug 25, 2025Schreiber TaylorChief Executive OfficerAward25,610$22.22KForm 4
Aug 25, 2025Ashiya MonaDirectorBuy1,051,021$911.97KForm 4
Aug 25, 2025Ashiya MonaDirectorBuy5,255,106$4.56MForm 4
Aug 25, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP IX LLC & OrbiMed Genesis GP LLCDirectorBuy1,051,021$911.97KForm 4
Aug 25, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP IX LLC & OrbiMed Genesis GP LLCDirectorBuy5,255,106$4.56MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related